NZ325587A - 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity - Google Patents

4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Info

Publication number
NZ325587A
NZ325587A NZ325587A NZ32558796A NZ325587A NZ 325587 A NZ325587 A NZ 325587A NZ 325587 A NZ325587 A NZ 325587A NZ 32558796 A NZ32558796 A NZ 32558796A NZ 325587 A NZ325587 A NZ 325587A
Authority
NZ
New Zealand
Prior art keywords
dihydronaphth
isoxazoles
derivatives
cns activity
cns
Prior art date
Application number
NZ325587A
Other languages
English (en)
Inventor
Nicholas J Hrib
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NZ325587A publication Critical patent/NZ325587A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ325587A 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity NZ325587A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58331996A 1996-01-05 1996-01-05
PCT/US1996/019569 WO1997025317A1 (fr) 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles et leurs derives ayant une activite au niveau du systeme nerveux central

Publications (1)

Publication Number Publication Date
NZ325587A true NZ325587A (en) 1999-02-25

Family

ID=24332609

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ325587A NZ325587A (en) 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Country Status (14)

Country Link
EP (1) EP0874833A1 (fr)
JP (1) JP3161737B2 (fr)
KR (1) KR100308748B1 (fr)
CN (1) CN1214046A (fr)
AR (1) AR005347A1 (fr)
AU (1) AU710059B2 (fr)
BR (1) BR9612578A (fr)
CA (1) CA2241845C (fr)
HU (1) HUP9903706A3 (fr)
IL (1) IL125197A0 (fr)
NO (1) NO983100L (fr)
NZ (1) NZ325587A (fr)
WO (1) WO1997025317A1 (fr)
ZA (1) ZA9725B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2420235A1 (fr) * 2000-08-21 2002-02-28 Georgetown University Quinuclidines 2-3-disubstituees servant de modulateurs de transporteur de monoamine et procedes therapeutiques et diagnostiques se basant sur celles-ci
US7265103B2 (en) * 2002-04-02 2007-09-04 Janssen Pharmaceutica Nv. Substituted amino isoxazoline derivatives and their use as anti-depressants
AR040967A1 (es) 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
EP1554286B1 (fr) 2002-08-15 2010-01-27 Janssen Pharmaceutica N.V. Derives d'isoxazoline heterocycliques fusionnes et leur utilisation en tant qu'antidepresseurs
MY134287A (en) * 2002-08-21 2007-11-30 Janssen Pharmaceutica Nv C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants
US8025859B2 (en) 2007-05-18 2011-09-27 Cesl Limited Process for gold and silver recovery from a sulphide concentrate
EP2493866A1 (fr) 2009-10-29 2012-09-05 Bristol-Myers Squibb Company Composés hétérocycliques tricycliques
US10633354B2 (en) 2016-09-02 2020-04-28 Bristol-Myers Squibb Company Substituted tricyclic heterocyclic compounds
US11059784B2 (en) 2017-08-09 2021-07-13 Bristol-Myers Squibb Company Oxime ether compounds
US11046646B2 (en) 2017-08-09 2021-06-29 Bristol-Myers Squibb Company Alkylphenyl compounds
KR102002633B1 (ko) 2018-07-19 2019-07-22 김태효 완충이격부가 구비된 논슬립 발의류
KR102429797B1 (ko) 2019-12-31 2022-08-05 주식회사 제이패션 기능성 무재봉 덧신 및 이를 제조하는 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119977A1 (en) * 1971-04-23 1971-12-16 Teikoku Hormone Manufacturing Co , Ltd, Tokio Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation
EP0402644B1 (fr) * 1989-05-19 1995-08-16 Hoechst-Roussel Pharmaceuticals Incorporated N-(aryloxyalkyl)hétéroarylpipéridines et -hétéroarylpipérazines, leur procédé de préparation et leur application comme médicaments
US5670522A (en) * 1992-10-23 1997-09-23 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands

Also Published As

Publication number Publication date
CN1214046A (zh) 1999-04-14
AU1412697A (en) 1997-08-01
WO1997025317A1 (fr) 1997-07-17
BR9612578A (pt) 1999-07-27
KR19990077033A (ko) 1999-10-25
AU710059B2 (en) 1999-09-09
IL125197A0 (en) 1999-03-12
KR100308748B1 (ko) 2001-12-12
CA2241845C (fr) 2002-10-01
HUP9903706A3 (en) 2000-09-28
ZA9725B (en) 1997-07-07
AR005347A1 (es) 1999-04-28
JP3161737B2 (ja) 2001-04-25
NO983100L (no) 1998-09-04
NO983100D0 (no) 1998-07-03
EP0874833A1 (fr) 1998-11-04
JPH11510816A (ja) 1999-09-21
CA2241845A1 (fr) 1997-07-17
HUP9903706A2 (hu) 2000-08-28

Similar Documents

Publication Publication Date Title
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
EP0894807A4 (fr) COMPLEXE GPIb-LIPIDE ET SES UTILISATIONS
IL121298A0 (en) N-(4-aryl-thiazol-2-YL)-sulphonamide derivatives and their uses
PL329121A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
IL111223A (en) 3-phenylmethanoyl benzo [b] thiene derivatives and uses thereof
IL126968A0 (en) Alkylaminobenzothiazole and benzoxazole derivatives
HUP9904032A3 (en) 1,2,4-benzothiadiazine derivatives,their preparation and use
IL143095A0 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
NZ325587A (en) 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity
HUP9902901A3 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta[b]benzofurans
HK1023124A1 (en) Oxime derivatives and their use as fungicides
HUP9901875A3 (en) Isoxazolidine derivatives
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
SG70589A1 (en) 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives
PL315809A1 (en) Derivatives of 1,3,2-benzothiazole monoxide
GB9417969D0 (en) Alkaloids and derivatives thereof
IL120285A (en) Process for the preparation of 1,5-benzothiazepine derivatives, process for the preparation of the intermediate thereof and an intermediate thereof
ZA952526B (en) 1,2,4-triazolo[4,3-a]pyrazin-4-one derivatives and preparation thereof
PL301984A1 (en) Derivatives of 3-phenyl-5-methylisoxzaole and 4,5-dihydroisoxasole
HUP9903369A3 (en) 8(9)-dehydroestradiol derivatives
PL332044A1 (en) 25-methylene and 24,25-epoxy marcphortines and paraherquamides
HUP9803035A3 (en) 7-bromo- and 7,7-dibromo-cepham and cephem derivatives
IL117864A0 (en) Benzamidoxime derivatives their preparation and use
IL130921A0 (en) Tetrahydroisoindole and hexahydroisoindole derivatives